Glaxo SmithKline Pharmaceuticals disclosed a drop in standalone net profit for the quarter ended March 2014. During the quarter, the profit of the company declined 42.88% to Rs 965.40 million from Rs 1,690.00 million in the same quarter previous year.
Net sales for the quarter declined marginally 4.24% to Rs 6,099.00 million, compared with Rs 6,369.00 million for the prior year period.
Earnings per share for the quarter stood at Rs 11.40, registering 43.00% decline over previous year period.
Quarterly Results - Standalone (Rs in mn) |
As at | Mar - 14 | Mar - 13 | %Change |
Net Sales | 6,099.00 | 6,369.00 | (4.24) |
Net Profit | 965.40 | 1,690.00 | (42.88) |
Basic EPS | 11.40 | 20.00 | (43.00) |
Shares of the company declined Rs 33.1, or 1.32%, to trade at Rs 2,475.00. The total volume of shares traded was 2,521 at the BSE (2.37 p.m., Thursday).